Urge your U.S. Representatives to cosponsor immunosuppressive drug legislation

Support low-income kidney patients in California!

On December 23, 2019, Representatives Ron Kind (D-WI) and Michael Burgess (R-TX) introduced legislation that would lift the three year limit on Medicare coverage of immunosuppressive drugs for kidney transplant patients. Please contact your Representative today and ask them to cosponsor this important legislation.

For Americans living with end-stage renal disease (ESRD), transplants are the best and most desired treatment. In the United States today there are about 80,000 patients waiting for a kidney transplant, and the wait time can be years. Only one in five people on the wait list will receive an organ. A transplanted kidney is immeasurably valuable to the recipient, their family, and society.

People living with a kidney transplant rely on immunosuppressive drugs to ensure that their body does not reject their kidney. If they have Medicare coverage, it will cover their health care, including immunosuppressive drugs, for 36 months after the date of their transplant surgery. After those three years, if the patient is under the age of 65, Medicare will no longer cover the individual or their needed medications. In cases where ESRD patients cannot find alternative health insurance and they can’t afford to pay for their immunosuppressive drugs out-of-pocket, they ultimately lose their kidney and must go back on dialysis.

Recipients

  • Your Representative

Contact

*Required fields
 

The following questions are for AKF internal use only

1.
Question - Not Required - What is your connection to kidney disease?










2.


 

Once you submit the form, your personalized message will be sent directly to your State Senator.

 
 

Message

Please cosponsor H.R. 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019.

Dear [Decision Maker],

As your constituent and as someone who has been touched by kidney disease, I'm writing today to ask for your support of extending Medicare coverage of immunosuppressive drugs to the life of the kidney transplant recipient by cosponsoring H.R. 5534, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019

For Americans living with end-stage renal disease (ESRD), transplants are the best and most desired treatment. In the United States today there are about 80,000 patients waiting for a kidney transplant, and the wait time can be years. Only one in five people on the wait list will receive an organ. A transplanted kidney is immeasurably valuable to the recipient, their family, and society.

Those individuals, who are living with a kidney transplant, rely on immunosuppressive drugs to ensure that their body does not reject their kidney. If Medicare was the insurance for the patient, Medicare will cover their health care, which includes immunosuppressive drugs, for 36 months after the date of their transplant surgery. After those three years, if the patient is under the age of 65, Medicare will no longer cover the individual or their needed medications. In cases where ESRD patients cannot find alternative health insurance and they can't afford to pay for their immunosuppressive drugs out-of-pocket, they ultimately lose their kidney and must go back on dialysis.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]